Correlation Between GH Research and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both GH Research and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GH Research PLC and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on GH Research and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and PsyBio Therapeutics.
Diversification Opportunities for GH Research and PsyBio Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between GHRS and PsyBio is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of GH Research i.e., GH Research and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between GH Research and PsyBio Therapeutics
Given the investment horizon of 90 days GH Research PLC is expected to generate 0.24 times more return on investment than PsyBio Therapeutics. However, GH Research PLC is 4.16 times less risky than PsyBio Therapeutics. It trades about 0.12 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about -0.21 per unit of risk. If you would invest 810.00 in GH Research PLC on September 1, 2024 and sell it today you would earn a total of 83.00 from holding GH Research PLC or generate 10.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
GH Research PLC vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
| GH Research PLC |
| PsyBio Therapeutics Corp |
GH Research and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GH Research and PsyBio Therapeutics
The main advantage of trading using opposite GH Research and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| GH Research vs. Molecular Partners AG | GH Research vs. MediciNova | GH Research vs. Anebulo Pharmaceuticals | GH Research vs. Champions Oncology |
| PsyBio Therapeutics vs. Rigel Pharmaceuticals | PsyBio Therapeutics vs. Geron | PsyBio Therapeutics vs. Verastem | PsyBio Therapeutics vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |